Year To Quarter End Consolidated Statement Of Comprehensive Income

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7607422

Concept 2021-03-01 to
2022-02-28
2021-03-01 to
2022-02-28
2021-03-01 to
2022-02-28
2021-03-01 to
2022-02-28
2021-03-01 to
2022-02-28
2020-03-01 to
2021-02-28
2020-03-01 to
2021-02-28
2020-03-01 to
2021-02-28
2020-03-01 to
2021-02-28
2020-03-01 to
2021-02-28
Year to quarter end consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
7,169,000,000 JPY
7,169,000,000 JPY
7,169,000,000 JPY
9,862,000,000 JPY
7,169,000,000 JPY
8,342,000,000 JPY
8,342,000,000 JPY
8,342,000,000 JPY
8,342,000,000 JPY
9,433,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-1,065,000,000 JPY
4,070,000,000 JPY
Foreign currency translation adjustment
6,761,000,000 JPY
-3,901,000,000 JPY
Remeasurements of defined benefit plans, net of tax
475,000,000 JPY
277,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
-7,000,000 JPY
46,000,000 JPY
Other comprehensive income
6,020,000,000 JPY
492,000,000 JPY
Comprehensive income
15,883,000,000 JPY
9,926,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
15,724,000,000 JPY
9,771,000,000 JPY
Comprehensive income attributable to non-controlling interests
158,000,000 JPY
154,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.